Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Soliris Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Soliris Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Plasma Exchange
      • 1.3.3 Plasma Infusion
    • 1.4 Market Segment by Application
      • 1.4.1 Global Soliris Drug Market Share by Application (2019-2025)
      • 1.4.2 PNH
      • 1.4.3 aHUS
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Soliris Drug Market Size
      • 2.1.1 Global Soliris Drug Revenue 2014-2025
      • 2.1.2 Global Soliris Drug Sales 2014-2025
    • 2.2 Soliris Drug Growth Rate by Regions
      • 2.2.1 Global Soliris Drug Sales by Regions 2014-2019
      • 2.2.2 Global Soliris Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Soliris Drug Sales by Manufacturers
      • 3.1.1 Soliris Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Soliris Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Soliris Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Soliris Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Soliris Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Soliris Drug Price by Manufacturers
    • 3.4 Key Manufacturers Soliris Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Soliris Drug Market
    • 3.6 Key Manufacturers Soliris Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Plasma Exchange Sales and Revenue (2014-2019)
      • 4.1.2 Plasma Infusion Sales and Revenue (2014-2019)
    • 4.2 Global Soliris Drug Sales Market Share by Type
    • 4.3 Global Soliris Drug Revenue Market Share by Type
    • 4.4 Soliris Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Soliris Drug Sales by Application

    6 United States

    • 6.1 United States Soliris Drug Breakdown Data by Company
    • 6.2 United States Soliris Drug Breakdown Data by Type
    • 6.3 United States Soliris Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Soliris Drug Breakdown Data by Company
    • 7.2 European Union Soliris Drug Breakdown Data by Type
    • 7.3 European Union Soliris Drug Breakdown Data by Application

    8 China

    • 8.1 China Soliris Drug Breakdown Data by Company
    • 8.2 China Soliris Drug Breakdown Data by Type
    • 8.3 China Soliris Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Soliris Drug Breakdown Data by Company
    • 9.2 Rest of World Soliris Drug Breakdown Data by Type
    • 9.3 Rest of World Soliris Drug Breakdown Data by Application
    • 9.4 Rest of World Soliris Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Soliris Drug Sales by Countries
      • 9.4.2 Rest of World Soliris Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Alexion
      • 10.1.1 Alexion Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Soliris Drug
      • 10.1.4 Soliris Drug Product Introduction
      • 10.1.5 Alexion Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Soliris Drug Sales Channels
      • 11.2.2 Soliris Drug Distributors
    • 11.3 Soliris Drug Customers

    12 Market Forecast

    • 12.1 Global Soliris Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Soliris Drug Sales Forecast by Type
    • 12.3 Global Soliris Drug Sales Forecast by Application
    • 12.4 Soliris Drug Forecast by Regions
      • 12.4.1 Global Soliris Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Soliris Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
      In 2019, the market size of Soliris Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Soliris Drug.

      This report studies the global market size of Soliris Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Soliris Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Alexion
      ...

      Market Segment by Product Type
      Plasma Exchange
      Plasma Infusion

      Market Segment by Application
      PNH
      aHUS
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Soliris Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Soliris Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Soliris Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now